The expression of AT1 receptor on hepatic stellate cells in rat fibrosis induced by CCl4

Chinese Medical Journal

Volumn 114, Issue 6, 2001, Pages 583-587

  Wei, HongshanWei S ^a   Lu, Hanming M ^a   Li, Dingguo G ^a   Zhan, Yutao T ^a   Wang, Zhirong R ^a   Huang, Xin ^a  

^a XINHUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Enalapril; Hepatic fibrosis; Losartan; Receptor; Renin angiotensin system

Indexed keywords

ALANINE AMINOTRANSFERASE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ASPARTATE AMINOTRANSFERASE; CARBON TETRACHLORIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; LOSARTAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL ISOLATION; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; FIBROGENESIS; LIVER CELL; LIVER FIBROSIS; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; STELLATE CELL;

ALANINE TRANSAMINASE; ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ASPARTATE AMINOTRANSFERASES; CARBON TETRACHLORIDE; CELLS, CULTURED; ENALAPRIL; FIBROSIS; IMMUNOHISTOCHEMISTRY; LIVER; LOSARTAN; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, ANGIOTENSIN; RENIN-ANGIOTENSIN SYSTEM;

EID: 0034968140     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Marra F. Hepatic stellate cells and the regulation of liver inflammation. J Hepatol 1999;31:1120-1130.
2. Li D, Friedman SL. Liver fibrogenesis and the role of hepatic stellate cells: new insights and prospects for therapy. J Gastroenterol Hepatol 1999;14:618-633.
3. Friedman SL. The virtuosity of hepatic stellate cells. Gastroenterology 1999;117:1244-1246.
4. Knittel T, Kobold D, Saile B, et al. Rat liver myofibroblasts and hepatic stellate cells: different cell populations of the fibroblast lineage with fibrogenic potential. Gastroenterology 1999;117: 1205-1221.
5. George J, Roulot D, Koteliansky VE, et al. In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: a potential new therapy for hepatic fibrosis. Proc Natl Acad Sci U S A 1999;96:1219-1224.
6. Silvestre JS, Heymes C, Oubenaissa A, et al. Activation of cardiac aldosterone production in rat myocardial infarction: effect of angiotensin II receptor blockade and role in cardiac fibrosis. Circulation 1999;99:2694-2701.
7. Harada K, Sugaya T, Murakami K, et al. Angiotensin II type 1A receptor knockout mice display less left ventricular remodeling and improved survival after myocardial infarction. Circulation 1999;100:2093-2099.
8. Metzger R, Bohle RM, Pauls K, et al. Angiotensin-converting enzyme in non-neoplastic kidney diseases. Kidney Int 1999;56: 1442-1454.
9. Wolf G, Ziyadeh FN, Stahl RA. Angiotensin II stimulates expression of transforming growth factor beta receptor type II in cultured mouse proximal tubular cells. J Mol Med 1999;77:556-564.
10. Wang R, Ramos C, Joshi I, et al. Human lung myofibroblast-derived inducers of alveolar epithelial apoptosis identified as angiotensin peptides. Am J Physiol 1999;277(6 Pt 1):L1158-L1164.
11. Wang R, Zagariya A, Ang E, et al. Fas-induced apoptosis of alveolar epithelial cells requires ANG II generation and receptor interaction. Am J Physiol 1999;277(6 Pt 1):L1245-L1250.
12. Hebert LA, Falkenhain ME, Nahman Jr NS, et al. Combination ACE inhibitor and angiotensin II receptor antagonist therapy in diabetic nephropathy. Am J Nephrol 1999;19:1-6.
13. Hisada Y, Sugaya T, Yamanouchi M, et al. Angiotensin II plays a pathogenic role in immune-mediated renal injury in mice. J Clin Invest 1999;103:627-635.
14. Uhal BD, Gidea C, Bargout R, et al. Captopril inhibits apoptosis in human lung epithelial cells: a potential antifibrotic mechanism. Am J Physiol 1998;275(5 Pt 1):L1013-L1017.
15. Hafizi S, Wharton J, Morgan K, et al. Expression of functional angiotensin-converting enzyme and AT1 receptors in cultured human cardiac fibroblasts. Circulation 1998;98:2553-2559.
16. Hisada Y, Sugaya T, Yamanouchi M, et al. Angiotensin II receptors. J Am Soc Nephrol 1999;10(Suppl 11):S30-S39.
17. 2+ exchanger emerges in hepatic stellate cells after activation in association with liver fibrosis. Proc Natl Acad Sci U S A 1998;95:5389-5394.
18. Yoo KH, Thornhill BA, Wolstenholme JT, et al. Tissue-specific regulation of growth factors and clusterin by angiotensin II. Am J Hypertens 1998;11(6 Pt 1):715-722.
19. Grohe C, Kahlert S, Lobbert K, et al. Angiotensin converting enzyme inhibition modulates cardiac fibroblast growth. J Hypertens 1998;16:377-384.
20. Sano H, Okamoto H, Kitabatake A, et al. Increased mRNA expression of cardiac renin-angiotensin system and collagen synthesis in spontaneously hypertensive rats. Mol Cell Biochem 1998;178:51-58.
21. Kawano H, Do YS, Kawano Y, et al. Angiotensin II has multiple profibrotic effects in human cardiac fibroblasts. Circulation 2000;101:1130-1137.
22. Ju H, Zhao S, Jassal DS, et al. Effect of AT1 receptor blockade on cardiac collagen remodeling after myocardial infarction. Cardiovasc Res 1997;35:223-232.
23. Ryoke T, Gu Y, Mao L, et al. Progressive cardiac dysfunction and fibrosis in the cardiomyopathic hamster and effects of growth hormone and angiotensin-converting enzyme inhibition. Circulation 1999;100:1734-1743.
24. Border WA, Noble NA. Interactions of transforming growth factor-beta and angiotensin II in renal fibrosis. Hypertension 1998;31(1 Pt 2):181-188.
25. Powell EE, Edwards-Smith CJ, Hay JL, et al. Host genetic factors influence disease progression in chronic hepatitis C. Hepatology 2000;31:828-833.